Loading…
Lobbying Spend
—
Filings
7
Firms Hired
1
Active Period
2021–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4281
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5585
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6000
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7667
Ending the Diagnostic Odyssey Act of 2021
2022 · third_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: S. 2022
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: S. 2209
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: S. 3534
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: S. 3799
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: S. 3819
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Chips and Science Act (PL 117-167); H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act; Issues related to reauthorization of FDA user fee bills H.R. 7667, Food and Drug Amendments of 2022; S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including H.R. 4281/S. 2209, VALID Act
Client expense: — · Firm income: $60,000
Matched citations: S. 4348
United States Innovation and Competition Act of 2021
2022 · second_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4521
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5585
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6000
United States Innovation and Competition Act of 2021
2022 · second_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: S. 1260
Ending the Diagnostic Odyssey Act of 2021
2022 · second_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: S. 2022
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: S. 3534
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: S. 3799
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor Conference negotiations between H.R. 4521, America COMPETES Act of 2022 and S. 1260, United States Innovation and Competition Act of 2021 and their efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act; S. 3819, Advanced Research Project Authority for Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: S. 3819
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.2731
United States Innovation and Competition Act of 2021
2022 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 4521
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5585
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6000
COVID Supplemental Appropriations Act, 2022
2022 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: H.R. 7007
United States Innovation and Competition Act of 2021
2022 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: S. 1260
Ending the Diagnostic Odyssey Act of 2021
2022 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to genomics, sequencing, and surveillance; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R.2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; S. 3534, Tracking Pathogens Act
Client expense: — · Firm income: $60,000
Matched citations: S. 2022
Source: Senate LDA